Filing Details

Accession Number:
0000950170-24-138086
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-18 19:41:34
Reporting Period:
2024-12-16
Accepted Time:
2024-12-18 19:41:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1816736 Disc Medicine Inc. IRON () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1586788 D John Quisel C/O Disc Medicine, Inc.
321 Arsenal Street, Suite 101
Watertown MA 02472
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-12-16 12,791 $1.01 84,856 No 4 M Direct
Common Stock Disposition 2024-12-16 219 $64.66 84,637 No 4 S Direct
Common Stock Disposition 2024-12-16 5,767 $65.58 78,870 No 4 S Direct
Common Stock Disposition 2024-12-16 6,305 $66.35 72,565 No 4 S Direct
Common Stock Disposition 2024-12-16 500 $67.20 72,065 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-12-16 12,791 $0.00 12,791 $1.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
225,420 2030-03-10 No 4 M Direct
Footnotes
  1. The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on July 2, 2024.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.04 to $65.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.04 to $66.03, inclusive.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.04 to $67.01, inclusive.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.04 to $67.54, inclusive.
  6. The shares underlying this option are fully vested and exercisable as of the date hereof.